These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 7745355

  • 41. [Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases].
    Giansante C, Di Chiara A, Fiotti N, Mauri F, Sorrentino A, Spanghero M, Tomasin L, Calabrese S.
    Clin Ter; 1990 Sep 15; 134(5):301-5. PubMed ID: 2149312
    [Abstract] [Full Text] [Related]

  • 42. [Therapy of arterial-circulation disorders in the legs. Muscle-ergometric studies under the effects of butalamine hydrochloride in a double-blind trial].
    Bopp J.
    Fortschr Med; 1976 Apr 22; 94(12):725-7. PubMed ID: 823084
    [Abstract] [Full Text] [Related]

  • 43. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L, Gandolfo AM, Utz C.
    MMW Munch Med Wochenschr; 1984 Mar 02; 126(9):247-8. PubMed ID: 6425678
    [No Abstract] [Full Text] [Related]

  • 44. A double-blind, multicenter, placebo-controlled, dose comparison study of orally administered defibrotide: preliminary results in patients with peripheral arterial disease.
    Strano A, Fareed J, Sabbá C, Albano O, Allegra C, Carlizza A, Binaghi F, Fronteddu F, Del Guercio R, Arpaia MR.
    Semin Thromb Hemost; 1991 Mar 02; 17 Suppl 2():228-34. PubMed ID: 1948094
    [Abstract] [Full Text] [Related]

  • 45. [Treatment of peripheral occlusive vascular disease with pentoxifylin (author's transl)].
    Traumann KJ.
    Med Klin; 1976 Mar 12; 71(11):465-8. PubMed ID: 1263995
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. A double blind study with melperone and placebo in the treatment of chronic alcoholics.
    Carlsson C, Gullberg B.
    Int J Clin Pharmacol Biopharm; 1978 Jul 12; 16(7):331-2. PubMed ID: 352974
    [Abstract] [Full Text] [Related]

  • 51. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
    Angelkort B, Doppelfeld E.
    Med Klin; 1978 May 26; 73(21):791-7. PubMed ID: 651768
    [Abstract] [Full Text] [Related]

  • 52. A pilot evaluation of the effect of defibrotide in patients affected by peripheral arterial occlusive disease.
    Sabbá C, Zupo V, Dina F, Nazzari M, Albano O.
    Int J Clin Pharmacol Ther Toxicol; 1988 May 26; 26(5):249-52. PubMed ID: 3045026
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Essential arterial hypertension and Leriche-Fontaine stage II obliterating vascular disease of the lower limbs. A new pharmacological approach with ketanserin].
    Mollo P.
    Clin Ter; 1991 Apr 30; 137(2):113-5. PubMed ID: 1828404
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Conservative treatment of peripheral arterial occlusive diseases].
    Hoffmann J.
    Fortschr Med; 1978 Sep 14; 96(34):1735-8. PubMed ID: 101431
    [Abstract] [Full Text] [Related]

  • 60. [Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].
    Ambrosi V, Gabrielli F.
    Minerva Med; 1983 Mar 31; 74(13):685-9. PubMed ID: 6220230
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.